# MicroOptx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/microoptx

- Industry: Medical Devices & Equipment
- Headquarters: Maple Grove, US
- Website: www.microoptx.com
- Total disclosed funding: $3M
- Latest round: Series C (Aug 5, 2019)
- Investors on record: 1

## About

Based in Minnesota, US, and founded in 2014, MicroOptx operates as a medical device glaucoma company that offers platform technology to shunt aqueous humour from the anterior chamber to the surface of the eye. In August 2019, MicroOptx raised USD 3 million in series C funding from investor HBM Partners. As of 2023, the company is led by its CEO, Chris Pulling.

Thesaurus Systems offers minimally invasive glaucoma surgical devices (MIGS) used for the treatment of glaucoma by resisting bacterial encroachment. The company consists of hydrophilic hydrogel that scoops aqueous out of the eye surface, lowering intraocular pressure and preventing blindness.

## Funding rounds

- Series C, Aug 5, 2019, $3M — HBM Partners

## Investors

- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series C